Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03533660
Other study ID # R21AA025730
Secondary ID R21AA025730
Status Completed
Phase N/A
First received
Last updated
Start date September 13, 2018
Est. completion date June 28, 2021

Study information

Verified date November 2022
Source University of Pittsburgh
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Successful treatment of alcohol associated liver disease (AALD) depends primarily on abstinence from alcohol. The investigators propose a randomized clinical trial of alcohol biosensor monitoring for patients with alcohol associated liver disease to determine if monitoring with feedback on alcohol use patterns reduces alcohol consumption and improves outcomes.


Description:

The investigators propose a 3 month randomized controlled trial (RCT) pilot of alcohol biosensor monitoring (ABM)(WrisTAS) for patients with Alcohol Associated Liver Disease (AALD) who intend to stop drinking. All participants will wear the ABM device but participants will be randomized to receive either personalized feedback on the data recorded on the device (n=30) or enhanced usual care without feedback on device data (n=30). The investigators will determine whether ABM plus feedback improves outcomes for AALD patients compared to enhanced usual care and hypothesize ABM feedback will reduce alcohol consumption, improve motivation and self-efficacy for abstinence and improve engagement in treatment. The investigators will also conduct research including qualitative data collected from participants who will provide opinions on ABM feasibility, acceptability, and usability. Qualitative methods are especially useful for understanding the perceived needs, barriers, and preferences for monitoring alcohol use and are especially required for future translation of this technology into clinical practice.


Recruitment information / eligibility

Status Completed
Enrollment 33
Est. completion date June 28, 2021
Est. primary completion date February 28, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients with AALD followed at our liver disease clinic, - 18 years or older, - willing to accept randomization, - and agree to wear device for 3 months, - SOCRATES problem recognition subscale score >26 (scores <26 indicate very low recognition of an alcohol problem). Exclusion Criteria: - Non-English speaking, - Montreal Cognitive Assessment (MOCA) scores <21 (moderate cognitive impairment) or neurologic diseases (e.g. Parkinson's), - patients with unresponsive acute alcoholic hepatitis, multi-organ failure, fulminant hepatic failure, - cancer/terminal illness; - those unable to wear a wrist monitor (e.g., edema); - lacking a residence, or unable to identify a contact person (if lost to follow-up).

Study Design


Intervention

Behavioral:
Feedback
Participant will receive a brief feedback on alcohol use data downloaded from the ABM and information about treatment resources
Enhanced Usual Care
Participant will receive information on self reported alcohol use and information about remaining abstinent and about treatment resources

Locations

Country Name City State
United States University of Pittsburgh Medical Center Pittsburgh Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
University of Pittsburgh National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Alcohol Use Average number of drinks per drinking episode per interval (month) of device wear. We analyzed the number of drinks per drinking episode and present the group average per month interval of assessment. continuous for up to 3 months
Primary Percent of Days Drinking Per Interval of Device Wear Percent of days drinking per interval of device wear: We analyzed the data by number of drinking episodes per individual per days of device wear and present the mean percent days drinking per assessment interval 3 months
Secondary Improved Readiness for Alcohol Abstinence and Initiation of Change Stages of Change Readiness & Treatment Eagerness Scale (SOCRATES) is a 19-item instrument that measures readiness for change assessing three areas; ambivalence, recognition, and taking steps with change scores assessing the impact of an intervention on these areas. Three subscale scores are produced with total scores ranging 19-95 and higher score indicating greater readiness:
7 items for recognition of an alcohol problem (scores range from low of 7 to highest of 35)
4 items for ambivalence (range from low of 4 to highest of 20)
8 items for taking steps to make a positive change in drinking (range from low of 8 to highest of 40)
Scores determined at initiation, 6 weeks and 3 months of participation
Secondary Self Efficacy to Remain Abstinent Alcohol Abstinence Self-efficacy (AASE) evaluates confidence in ability to abstain from drinking in situations that represent typical drinking cues. Four subscales with 5 specific situations each are rated on confidence not to drink in each situations on a 5-point Likert scale from 1=not at all confident to 5=extremely confident. Total scores range from 20-100 with higher scores reflecting greater self confidence not to drink.
negative affect situations (range from low confidence of 5 to highest confidence of 25)
social/positive situations (range from low confidence of 5 to highest confidence of 25)
physical and other concerns situations (range from low confidence of 5 to highest confidence of 25)
cravings and urges situations (range from low confidence of 5 to highest confidence of 25)
Scores determined at initiation, 6 weeks and 3 months of participation
Secondary Medical Outcomes AALD related hospitalizations and ER visits - total count of participants in each arm who experienced these outcomes Counts determined at initiation, 6 weeks and 3 months of participation
Secondary Qualitative Interviews Qualitative interviews of participants will use a semi-structured script of open-ended stem questions with prompts. The qualitative assessment will cover such topics as patients' perceived need/psychologic barriers (e.g., beliefs in value of ABM in their clinical care and for their relationship with clinicians) and experience with ABM (e.g., wearability, satisfaction, and barriers to monitoring). Transcribed interviews will be thematically coded. The constant comparison method will be used, and subsequent interviews may be modified/informed by findings from previous interviews to explore emerging themes as the analysis proceeds. measured at three months (completion of the participants use of ABM)
See also
  Status Clinical Trial Phase
Withdrawn NCT04659278 - Endourage Complete Spectrum Oral Mucosal Drops (OMD) in Adults Desiring a Reduction in Ethanol Use N/A
Completed NCT03928418 - Mobile Technology to Extend Clinic-based Counseling for HIV+s in Uganda N/A
Not yet recruiting NCT03967262 - Secondary Prevention and Recidivism Reduction in Trauma Patients N/A
Completed NCT05358613 - My Choices: Efficacy and Implementation Study N/A
Not yet recruiting NCT04856033 - Transcendental Meditation and PTSD Phase 3
Recruiting NCT05779774 - WayToServePlus: Improving Responsible Alcohol Service Ph II N/A
Completed NCT05065918 - Text Message Intervention for Alcohol Use and Sexual Violence in College Students N/A
Completed NCT05235971 - Behavioral Economic Treatment to Enhance Rural (BETTER) Living N/A
Recruiting NCT06324929 - Optimizing a Digital AEP Risk Intervention With Native Women and Communities Aim 1 N/A
Active, not recruiting NCT03892265 - A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti
Completed NCT03867812 - Effect of Different Foods Together With a Small Dose of Alcohol on Alcohol Levels in Healthy Subjects N/A
Recruiting NCT06191861 - Narrative Writing to Promote Healthy Decisions About Alcohol During the Transition Out of High School N/A
Recruiting NCT04474444 - Ambulance Calls for Substance Use and Alcohol in a Pandemic (ASAP)
Recruiting NCT04595682 - Estradiol Effects on Alcohol Across the Menstrual Cycle N/A
Completed NCT04595084 - Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use N/A
Recruiting NCT05837728 - Health Determinants in Older Adults Living at Home
Recruiting NCT05580549 - Prevalence of Hazardous Alcohol Use in a Population With Hypertension in Primary Care
Completed NCT03982433 - Internet-based Videoconferencing to Address Alcohol Use and Pain N/A
Not yet recruiting NCT06401967 - Study of a Smartphone-Based Alcohol Reduction Program N/A
Recruiting NCT06259916 - Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG) N/A